{"entity":{"type":"insider","cik":"0001742143","url":"/insider/0001742143","json_url":"/insider/0001742143.json","name":"Pizzie Nick","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":9,"first":"2018-06-20","last":"2026-06-09","span_basis":"filed_date"},"name_variants":[{"name":"Pizzie Nick","source":"filing","n_filings":9,"first_seen":"2018-06-20","last_seen":"2026-06-09"}],"transactions":[{"id":5810347,"accession":"0001193125-26-264035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-264035","line_url":"/filing/0001193125-26-264035#line-2","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001742143","owner_name":"Pizzie Nick","owner_display_name":"Pizzie Nick","owner_url":"/insider/0001742143","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33000.0,"shares_display":"33,000","price_per_share":240.09,"price_display":"240.09","price_state":"stated","total_value":7922970.0,"total_display":"7,922,970.00","total_whole":"7,922,970","shares_owned_after":42867.0,"shares_owned_after_display":"42,867","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-09","filed_date":"2026-06-09","scope":"insider"},{"id":5809356,"accession":"0001193125-26-021378","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-021378","line_url":"/filing/0001193125-26-021378#line-2","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001742143","owner_name":"Pizzie Nick","owner_display_name":"Pizzie Nick","owner_url":"/insider/0001742143","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":187.92,"price_display":"187.92","price_state":"stated","total_value":2255040.0,"total_display":"2,255,040.00","total_whole":"2,255,040","shares_owned_after":42588.0,"shares_owned_after_display":"42,588","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-23","scope":"insider"},{"id":4582281,"accession":"0000950170-25-021716","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-021716","line_url":"/filing/0000950170-25-021716#line-4","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001742143","owner_name":"Pizzie Nick","owner_display_name":"Pizzie Nick","owner_url":"/insider/0001742143","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":131.07,"price_display":"131.07","price_state":"stated","total_value":393210.0,"total_display":"393,210.00","total_whole":"393,210","shares_owned_after":42187.0,"shares_owned_after_display":"42,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-14","filed_date":"2025-02-14","scope":"insider"},{"id":4582272,"accession":"0000950170-25-021716","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-021716","line_url":"/filing/0000950170-25-021716#line-2","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001742143","owner_name":"Pizzie Nick","owner_display_name":"Pizzie Nick","owner_url":"/insider/0001742143","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":129.86,"price_display":"129.86","price_state":"stated","total_value":1558320.0,"total_display":"1,558,320.00","total_whole":"1,558,320","shares_owned_after":42187.0,"shares_owned_after_display":"42,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-14","scope":"insider"},{"id":5385187,"accession":"0001209191-21-066005","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-066005","line_url":"/filing/0001209191-21-066005","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001742143","owner_name":"Pizzie Nick","owner_display_name":"Pizzie Nick","owner_url":"/insider/0001742143","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":955.0,"shares_display":"955","price_per_share":35.26285863874345,"price_display":"35.26","price_state":"stated","total_value":33676.03,"total_display":"33,676.03","total_whole":"33,676","shares_owned_after":41789.0,"shares_owned_after_display":"41,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-22","scope":"insider","n_lines":4},{"id":2743371,"accession":"0001104659-20-078440","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-078440","line_url":"/filing/0001104659-20-078440#line-1","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001742143","owner_name":"Pizzie Nick","owner_display_name":"Pizzie Nick","owner_url":"/insider/0001742143","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":777.0,"shares_display":"777","price_per_share":76.64,"price_display":"76.64","price_state":"stated","total_value":59549.28,"total_display":"59,549.28","total_whole":"59,549","shares_owned_after":41217.0,"shares_owned_after_display":"41,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-29","filed_date":"2020-06-30","scope":"insider"},{"id":8726863,"accession":"0001104659-19-051908","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-051908","line_url":"/filing/0001104659-19-051908#line-1","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001742143","owner_name":"Pizzie Nick","owner_display_name":"Pizzie Nick","owner_url":"/insider/0001742143","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2180.0,"shares_display":"2,180","price_per_share":24.8,"price_display":"24.80","price_state":"stated","total_value":54064.0,"total_display":"54,064.00","total_whole":"54,064","shares_owned_after":40440.0,"shares_owned_after_display":"40,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-26","filed_date":"2019-09-30","scope":"insider"},{"id":8613968,"accession":"0001104659-19-034903","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-034903","line_url":"/filing/0001104659-19-034903#line-1","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001742143","owner_name":"Pizzie Nick","owner_display_name":"Pizzie Nick","owner_url":"/insider/0001742143","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1920.0,"shares_display":"1,920","price_per_share":20.8,"price_display":"20.80","price_state":"stated","total_value":39936.0,"total_display":"39,936.00","total_whole":"39,936","shares_owned_after":1920.0,"shares_owned_after_display":"1,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-11","filed_date":"2019-06-12","scope":"insider"},{"id":8475848,"accession":"0001104659-19-016424","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-016424","line_url":"/filing/0001104659-19-016424","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001742143","owner_name":"Pizzie Nick","owner_display_name":"Pizzie Nick","owner_url":"/insider/0001742143","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5400.0,"shares_display":"5,400","price_per_share":12.581222222222221,"price_display":"12.58","price_state":"stated","total_value":67938.6,"total_display":"67,938.60","total_whole":"67,939","shares_owned_after":36340.0,"shares_owned_after_display":"36,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-19","filed_date":"2019-03-21","scope":"insider","n_lines":2},{"id":6288825,"accession":"0001104659-18-041289","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-041289","line_url":"/filing/0001104659-18-041289","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001742143","owner_name":"Pizzie Nick","owner_display_name":"Pizzie Nick","owner_url":"/insider/0001742143","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":31000.0,"shares_display":"31,000","price_per_share":3.099354838709677,"price_display":"3.10","price_state":"stated","total_value":96080.0,"total_display":"96,080.00","total_whole":"96,080","shares_owned_after":31000.0,"shares_owned_after_display":"31,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-19","filed_date":"2018-06-20","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":11,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001579428","name":"Axsome Therapeutics, Inc.","url":"/issuer/0001579428","role":"Officer (Chief Financial Officer)","n_filings":9,"first_seen":"2018-06-20","last_seen":"2026-06-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001742143","retrieved_at":"2026-08-25T12:56:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}